Adam Suleman

10PUBLICATIONS
24CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Virtual and mixed realityAllergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 06, 2025
An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators.

Catherine Tang, Catriona Downie, Mandeep S Sagoo

|Oct 27, 2023
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada.

Inna Y Gong, Anca Prica, Zharmaine Ante

|Jul 20, 2023
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario.

Adam Suleman, Suriya J Aktar, Zharmaine Ante

|Feb 23, 2023
Virtual Care During the COVID-19 Pandemic for Patients With Hematologic Malignancies: A Single-Institution Experience.

Adam Suleman, Abi Vijenthira, Zhihui Amy Liu

|Feb 24, 2022
The Use of Virtual Care in Patients with Hematologic Malignancies: A Scoping Review.

Adam Suleman, Abi Vijenthira, Alejandro Berlin

|Feb 08, 2021
Evaluation of the protein gap for detection of abnormal serum gammaglobulin level: an imperfect predictor.

Adam Suleman, D William Cameron, Vicente Corrales-Medina

Pageof 2

Frequent Collaborators

4 joint publications

Anca Prica

3 joint publications

Matthew Cheung

2 joint publications

Juthaporn Cowan

2 joint publications

Alejandro Berlin